Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Ionis Pharmaceuticals, Inc. Common Stock

IONS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
IONS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
IONS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
IONS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in IONS holdings by institutional investors

Quarterly net insider trading by IONS's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $150,000 Jul 17, 2026 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $150,000 Apr 09, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $140,000 Jan 18, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $140,000 Oct 15, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $90,000 Jul 16, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $90,000 Apr 16, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $80,000 Jan 16, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $80,000 Oct 15, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues

Former government officials who have lobbied for IONS

4 former government officials from 4 congressional offices at 2 lobbying firms have lobbied for IONS, most recently Jul 05, 2026.

  • Jon C. Porter
    Alanna Temme House Legislative Director, U.S. Representative Jon Porter Formerly with Jon C. Porter · LMH STRATEGIC SOLUTIONS · Jul 05, 2026
  • Martha Roby
    Sophie Khanahmadi House Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions Formerly with Martha Roby · LMH STRATEGIC SOLUTIONS · Apr 17, 2026
  • Allen Boyd
    Elizabeth Greer House New Chief of Staff, Rep. Allen Boyd (2001-2009) Formerly with Allen Boyd · FORBES-TATE · Sep 11, 2024
  • Mike Crapo
    Barrett Thornhill Senate New Legislative Assistant, Sen. Mike Crapo (2003-2006) Formerly with Mike Crapo · FORBES-TATE · Sep 11, 2024

IONS Estimated quarterly lobbying spending

IONS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
IONS Income Statement
IONS Balance Sheet
IONS Cash Flow
U.S. Patents

New IONS patent grants

  • Patent Title: Compounds and methods for reducing fus expression Sep. 15, 2026
  • Patent Title: Modulation of tmprss6 expression Aug. 08, 2017
  • Patent Title: 5′-end derivatives Aug. 08, 2017
  • Patent Title: Compositions and methods Jul. 25, 2017
  • Patent Title: Compositions comprising alternating 2′-modified nucleosides for use in gene modulation Jul. 18, 2017
  • Patent Title: Method of preparing oligomeric compounds using modified coupling protocols Jul. 11, 2017
  • Patent Title: Competitive modulation of micrornas Jul. 04, 2017
  • Patent Title: Oligomeric compounds comprising bicyclic nucleosides and uses thereof Jul. 04, 2017
  • Patent Title: Bicyclic morpholino compounds and oligomeric compounds prepared therefrom Jun. 27, 2017
  • Patent Title: Modulation of huntingtin expression Jun. 20, 2017
  • Patent Title: Compositions for modulating tau expression Jun. 20, 2017
  • Patent Title: Modulation of hepatitis b virus (hbv) expression Jun. 13, 2017
  • Patent Title: Modulation of prekallikrein (pkk) expression Jun. 06, 2017
  • Patent Title: Modulation of alpha synuclein expression May. 30, 2017
  • Patent Title: Methods for treating hypercholesterolemia May. 16, 2017
  • Patent Title: Compositions and methods for modulating tau expression May. 09, 2017
  • Patent Title: Modulation of apolipoprotein c-iii expression Apr. 18, 2017
  • Patent Title: Compounds and methods for modulating gene expression Apr. 11, 2017
  • Patent Title: Modulation of ube3a-ats expression Apr. 11, 2017
  • Patent Title: Compositions for modulating c9orf72 expression Mar. 28, 2017
  • Patent Title: Compounds and methods for modulating protein expression Mar. 28, 2017
  • Patent Title: Oligomeric compounds and compositions for the use in modulation of micrornas Mar. 21, 2017
  • Patent Title: Modulation of apolipoprotein c-iii (apociii) expression in lipoprotein lipase deficient (lpld) populations Mar. 14, 2017
  • Patent Title: Methods and compositions for modulating apolipoprotein (a) expression Feb. 21, 2017
  • Patent Title: Modulation of androgen receptor expression Feb. 14, 2017
  • Patent Title: Antisense modulation of gccr expression Feb. 14, 2017
  • Patent Title: Regulation of epigenetic control of gene expression Jan. 24, 2017
  • Patent Title: Antisense compounds Jan. 24, 2017
  • Patent Title: Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (malat-1) expression Jan. 17, 2017
  • Patent Title: Cancer treatment Jan. 10, 2017
  • Patent Title: Methods of treating kennedy's disease Dec. 20, 2016
  • Patent Title: Modulation of enhancer rna mediated gene expression Dec. 13, 2016
  • Patent Title: Compounds and methods for modulating interaction between proteins and target nucleic acids Dec. 13, 2016
  • Patent Title: Antisense compounds targeting genes associated with fibronectin Nov. 08, 2016
  • Patent Title: Antisense modulation of superoxide dismutase 1, soluble expression Oct. 25, 2016
  • Patent Title: Oligomeric compounds comprising tricyclic nucleosides and methods for their use Aug. 30, 2016
  • Patent Title: Cyclohexenyl nucleic acids analogs Aug. 09, 2016
  • Patent Title: Antisense modulation of gcgr expression Aug. 02, 2016
  • Patent Title: Antisense modulation of ptp1b expression Aug. 02, 2016
  • Patent Title: Method of preparing oligomeric compounds using modified capping protocols Aug. 02, 2016
  • Patent Title: Modulation of transthyretin expression Jul. 26, 2016
  • Patent Title: Modulation of apolipoprotein c-iii expression Jun. 14, 2016
  • Patent Title: Compositions and their uses directed to huntingtin May. 31, 2016
  • Patent Title: Antisense compounds targeting genes associated with usher syndrome May. 31, 2016
  • Patent Title: Methods and compositions for modulating alpha-1-antitrypsin expression May. 17, 2016
  • Patent Title: Methods for modulating kallikrein (klkb1) expression Apr. 26, 2016
  • Patent Title: Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom Apr. 26, 2016
  • Patent Title: Methods for modulating kallikrein (klkb1) expression Apr. 19, 2016
  • Patent Title: Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside Mar. 22, 2016
  • Patent Title: Modulation of huntingtin expression Mar. 01, 2016
Government Contracts

Estimated quarterly amount awarded to IONS from public contracts

IONS News

Recent insights relating to IONS

CNBC Recommendations

Recent picks made for IONS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IONS

IONS Analyst Ratings

IONS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
IONS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $IONS stock a Buy, Sell, or Hold?

  • What is the price target for $IONS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

IONS Top Shareholders
Shareholder
Shares Held
IONS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $IONS stock?

  • Who owns the most shares of $IONS stock?

  • What funds own $IONS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

IONS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view IONS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About IONS

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis marked its first two independent launches in 2025 for Tryngolza (for FCS) and Dawnzera (for HAE).

  • Address Carlsbad, CA
  • Market Cap 7.6 billion
  • Employees 1,402
  • Industrial Classification Pharmaceutical Preparations

Ionis Pharmaceuticals, Inc. Common Stock (IONS) Historical Stock Prices

Ionis Pharmaceuticals, Inc. Common Stock (IONS) closed at $45.75 on September 22, 2026. Over the past year its adjusted close ranged from $44.44 to $86.50. Daily prices go back to January 2, 2014, 3,179 trading days in all.

  • 1 month-23.42%
  • 3 months-39.79%
  • Year to date-42.17%
  • 1 year-25.44%
  • 3 years+7.12%
  • 5 years+22.98%
  • Max+14.75%
See every congressional and insider trade on the IONS price chart

Quiver Premium charts IONS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 44.96 46.13 44.44 45.75 45.75 4,236,217
Sep 21, 2026 44.95 45.25 44.20 44.90 44.90 4,521,358
Sep 18, 2026 46.75 46.75 44.27 44.44 44.44 7,369,358
Sep 17, 2026 46.68 47.42 45.75 46.75 46.75 4,079,573
Sep 16, 2026 47.38 47.59 44.66 44.84 44.84 7,958,214
Sep 15, 2026 51.37 51.37 46.72 47.25 47.25 6,812,465
Sep 14, 2026 54.88 55.50 51.31 51.44 51.44 5,974,753
Sep 11, 2026 55.94 56.16 54.16 54.21 54.21 2,175,778
Sep 10, 2026 55.75 55.77 54.91 55.65 55.65 3,057,309
Sep 9, 2026 56.38 56.96 55.70 56.02 56.02 3,037,757
Sep 8, 2026 52.15 57.43 52.15 56.71 56.71 9,175,745
Sep 4, 2026 58.36 58.96 57.78 58.09 58.09 2,671,092
Sep 3, 2026 60.42 60.42 57.47 58.13 58.13 4,347,907
Sep 2, 2026 60.25 61.77 59.77 61.33 61.33 1,845,866
Sep 1, 2026 60.37 60.99 59.78 59.88 59.88 1,872,594
Aug 31, 2026 61.06 61.06 59.70 60.36 60.36 2,017,160
Aug 28, 2026 60.62 61.69 60.35 61.05 61.05 1,850,852
Aug 27, 2026 63.48 63.48 62.34 62.43 62.43 1,625,581
Aug 26, 2026 63.50 63.55 62.44 63.36 63.36 2,152,847
Aug 25, 2026 62.53 64.19 62.19 63.57 63.57 2,435,239
Aug 24, 2026 60.53 62.07 59.70 62.04 62.04 2,207,101
Aug 21, 2026 59.64 60.91 59.06 59.74 59.74 2,723,906
Aug 20, 2026 60.02 60.41 58.60 58.76 58.76 2,124,846
Aug 19, 2026 60.11 61.35 59.61 60.80 60.80 3,137,560
Aug 18, 2026 58.41 60.19 58.02 59.62 59.62 3,192,640
Aug 17, 2026 57.11 58.74 56.41 58.63 58.63 2,000,182
Aug 14, 2026 55.16 57.24 55.16 57.24 57.24 1,353,737
Aug 13, 2026 56.50 56.81 55.56 55.87 55.87 1,220,460
Aug 12, 2026 55.01 57.06 54.91 56.53 56.53 1,999,667
Aug 11, 2026 56.79 57.16 55.37 55.42 55.42 2,407,128
Aug 10, 2026 56.10 57.66 56.10 56.94 56.94 2,399,897
Aug 7, 2026 54.73 56.60 54.40 56.56 56.56 2,009,277
Aug 6, 2026 54.59 55.42 54.02 54.49 54.49 2,592,317
Aug 5, 2026 55.17 55.36 53.58 54.19 54.19 2,122,267
Aug 4, 2026 54.85 55.22 53.87 55.07 55.07 2,688,216
Aug 3, 2026 52.66 54.54 52.16 54.49 54.49 3,212,858
Jul 31, 2026 53.33 53.33 51.28 51.77 51.77 2,570,536
Jul 30, 2026 53.92 54.04 52.65 53.28 53.28 2,875,352
Jul 29, 2026 55.09 55.35 53.50 54.04 54.04 3,129,432
Jul 28, 2026 56.56 56.56 54.00 55.30 55.30 2,805,274
Jul 27, 2026 56.92 57.09 55.79 55.96 55.96 2,584,895
Jul 24, 2026 56.32 57.36 56.19 56.55 56.55 3,094,731
Jul 23, 2026 53.71 57.48 53.35 55.87 55.87 3,834,344
Jul 22, 2026 51.16 54.06 50.01 54.01 54.01 8,732,966
Jul 21, 2026 52.75 54.13 52.26 53.39 53.39 3,074,069
Jul 20, 2026 54.47 54.80 52.82 52.95 52.95 2,167,064
Jul 17, 2026 54.10 54.69 53.76 54.39 54.39 2,572,809
Jul 16, 2026 53.95 55.98 53.38 54.65 54.65 3,805,259
Jul 15, 2026 54.48 54.88 53.51 54.73 54.73 3,577,545
Jul 14, 2026 55.80 56.45 54.53 54.93 54.93 4,700,265
Jul 13, 2026 57.91 57.91 56.11 56.75 56.75 5,097,949
Jul 10, 2026 64.27 64.44 58.20 58.25 58.25 11,444,106
Jul 9, 2026 67.78 70.35 64.10 64.27 64.27 20,447,626
Jul 8, 2026 85.56 86.74 83.92 84.46 84.46 2,280,833
Jul 7, 2026 84.42 86.67 82.95 86.33 86.33 2,646,707
Jul 6, 2026 82.11 84.01 81.19 83.18 83.18 1,847,437
Jul 2, 2026 79.53 81.99 79.11 81.80 81.80 2,301,899
Jul 1, 2026 79.13 79.48 77.95 79.19 79.19 1,442,398
Jun 30, 2026 81.17 81.24 79.21 79.29 79.29 2,380,302
Jun 29, 2026 81.00 82.53 79.95 80.69 80.69 2,806,623
Jun 26, 2026 78.80 82.63 78.80 81.18 81.18 3,828,331
Jun 25, 2026 76.69 79.55 76.25 78.34 78.34 2,583,536
Jun 24, 2026 76.40 79.00 76.03 76.52 76.52 2,485,706
Jun 23, 2026 75.89 77.31 75.77 75.99 75.99 1,405,415
Jun 22, 2026 74.85 76.56 74.12 75.89 75.89 1,956,125
Jun 18, 2026 75.00 75.66 73.50 74.12 74.12 2,984,374
Jun 17, 2026 73.09 75.12 72.55 74.31 74.31 1,788,351
Jun 16, 2026 73.93 73.95 72.30 73.09 73.09 1,801,390
Jun 15, 2026 73.49 74.27 72.88 73.96 73.96 1,506,352
Jun 12, 2026 73.82 74.35 72.57 73.28 73.28 1,964,868
Jun 11, 2026 73.34 74.47 72.76 73.82 73.82 2,234,438
Jun 10, 2026 74.43 75.85 72.83 73.32 73.32 1,595,746
Jun 9, 2026 74.77 75.79 73.53 74.58 74.58 1,568,661
Jun 8, 2026 74.33 74.43 73.14 73.54 73.54 1,620,750
Jun 5, 2026 75.24 75.96 73.81 74.48 74.48 1,982,003
Jun 4, 2026 74.01 75.88 73.82 75.13 75.13 1,241,131
Jun 3, 2026 72.68 74.12 72.02 73.82 73.82 1,303,889
Jun 2, 2026 74.85 75.22 72.56 72.97 72.97 2,086,205
Jun 1, 2026 75.67 76.19 74.70 75.38 75.38 1,467,682
May 29, 2026 77.54 78.10 76.39 76.50 76.50 1,675,660
May 28, 2026 76.58 78.00 75.34 77.33 77.33 1,603,088
May 27, 2026 76.24 77.40 76.23 76.49 76.49 1,341,369
May 26, 2026 76.00 76.74 74.73 76.07 76.07 1,279,224
May 22, 2026 75.71 76.80 75.00 75.56 75.56 1,579,206
May 21, 2026 74.76 76.48 74.21 75.78 75.78 2,295,157
May 20, 2026 74.67 75.69 73.97 75.06 75.06 2,005,309
May 19, 2026 72.76 74.15 72.00 73.84 73.84 1,519,490
May 18, 2026 74.58 74.78 71.93 72.52 72.52 2,211,491
May 15, 2026 75.89 75.93 73.32 74.23 74.23 2,119,183
May 14, 2026 79.00 79.19 75.31 75.68 75.68 1,798,305
May 13, 2026 75.67 78.03 75.08 77.60 77.60 1,360,373
May 12, 2026 76.03 77.13 75.38 75.83 75.83 1,408,887
May 11, 2026 76.03 77.01 74.85 75.38 75.38 1,533,667
May 8, 2026 76.45 77.40 75.24 75.71 75.71 1,656,234
May 7, 2026 76.56 76.56 74.87 76.02 76.02 1,885,704
May 6, 2026 75.62 77.42 75.29 76.85 76.85 1,799,880
May 5, 2026 75.84 76.96 74.82 75.25 75.25 850,248
May 4, 2026 75.28 76.00 74.47 75.45 75.45 1,689,516
May 1, 2026 74.86 76.17 72.94 75.28 75.28 1,821,465
Apr 30, 2026 74.91 77.76 73.81 74.76 74.76 2,430,344
Apr 29, 2026 72.06 74.95 71.30 74.83 74.83 3,675,234
Apr 28, 2026 72.71 73.10 71.17 71.78 71.78 2,396,291
Apr 27, 2026 74.04 75.10 72.21 72.23 72.23 2,311,634
Apr 24, 2026 74.09 74.51 72.33 73.27 73.27 1,817,367
Apr 23, 2026 74.96 76.06 73.23 74.09 74.09 1,377,408
Apr 22, 2026 75.22 75.44 74.00 74.83 74.83 2,024,007
Apr 21, 2026 75.87 75.96 73.80 74.78 74.78 1,818,784
Apr 20, 2026 75.50 75.62 74.58 74.87 74.87 1,106,829
Apr 17, 2026 75.66 76.33 74.95 75.71 75.71 1,719,446
Apr 16, 2026 76.42 76.53 73.91 75.26 75.26 1,873,899
Apr 15, 2026 77.10 77.18 75.77 76.82 76.82 1,288,372
Apr 14, 2026 74.88 77.38 74.88 76.76 76.76 1,595,277
Apr 13, 2026 75.17 77.17 74.56 74.95 74.95 1,650,871
Apr 10, 2026 77.02 77.14 74.53 75.17 75.17 1,581,578
Apr 9, 2026 74.98 76.97 74.62 76.43 76.43 1,200,978
Apr 8, 2026 76.07 76.48 74.30 74.98 74.98 1,266,771
Apr 7, 2026 74.05 74.27 72.42 73.89 73.89 1,118,312
Apr 6, 2026 74.54 75.47 73.56 74.33 74.33 1,440,939
Apr 2, 2026 73.74 75.13 73.35 74.79 74.79 1,791,632
Apr 1, 2026 75.70 76.48 74.79 75.13 75.13 1,664,978
Mar 31, 2026 73.64 75.92 73.45 75.09 75.09 1,852,352
Mar 30, 2026 73.12 73.21 71.48 72.52 72.52 2,045,479
Mar 27, 2026 74.00 74.05 71.86 72.15 72.15 1,948,364
Mar 26, 2026 72.25 75.63 70.50 74.24 74.24 3,884,070
Mar 25, 2026 70.68 73.61 70.68 72.70 72.70 2,994,308
Mar 24, 2026 70.27 70.64 68.90 69.68 69.68 1,844,404
Mar 23, 2026 72.25 73.15 70.67 70.79 70.79 2,198,127
Mar 20, 2026 71.51 72.59 70.50 70.99 70.99 2,920,652
Mar 19, 2026 71.40 71.94 70.51 71.32 71.32 2,247,918
Mar 18, 2026 71.84 72.30 70.92 71.67 71.67 2,180,298
Mar 17, 2026 72.35 73.30 71.92 72.33 72.33 1,985,030
Mar 16, 2026 71.58 72.88 71.29 72.34 72.34 3,231,515
Mar 13, 2026 73.21 74.16 70.42 71.19 71.19 1,972,137
Mar 12, 2026 74.30 74.30 72.01 72.34 72.34 2,461,797
Mar 11, 2026 75.15 76.00 74.54 74.79 74.79 1,895,367
Mar 10, 2026 75.36 77.03 74.51 75.66 75.66 2,785,714
Mar 9, 2026 73.50 75.63 73.45 75.36 75.36 3,215,157
Mar 6, 2026 73.97 75.16 73.15 74.04 74.04 1,904,239
Mar 5, 2026 78.16 79.04 74.27 75.16 75.16 2,969,830
Mar 4, 2026 79.16 80.06 77.67 79.45 79.45 2,503,118
Mar 3, 2026 80.42 81.40 78.50 78.66 78.66 2,045,143
Mar 2, 2026 79.27 82.75 79.27 81.96 81.96 3,098,359
Feb 27, 2026 80.59 82.10 80.06 81.15 81.15 2,773,689
Feb 26, 2026 80.32 82.44 78.92 80.60 80.60 3,330,043
Feb 25, 2026 81.75 85.11 80.47 80.93 80.93 3,188,709
Feb 24, 2026 84.66 85.47 83.45 85.45 85.45 2,384,832
Feb 23, 2026 82.71 84.96 82.71 84.60 84.60 1,724,186
Feb 20, 2026 82.85 83.63 81.64 83.15 83.15 2,832,477
Feb 19, 2026 81.50 83.33 80.39 83.14 83.14 2,023,972
Feb 18, 2026 81.26 83.06 80.98 82.22 82.22 1,950,099
Feb 17, 2026 80.30 82.53 80.23 81.36 81.36 1,889,525
Feb 13, 2026 81.18 82.56 79.78 80.60 80.60 1,931,201
Feb 12, 2026 84.20 84.91 81.20 81.78 81.78 1,734,659
Feb 11, 2026 84.19 84.96 82.00 84.35 84.35 1,104,176
Feb 10, 2026 84.49 84.81 83.57 84.29 84.29 1,382,673
Feb 9, 2026 86.13 86.49 84.61 84.79 84.79 1,738,204
Feb 6, 2026 84.85 86.59 84.17 86.50 86.50 1,996,521
Feb 5, 2026 84.51 86.74 82.89 83.48 83.48 2,677,732
Feb 4, 2026 85.72 85.95 82.55 84.99 84.99 3,010,014
Feb 3, 2026 83.00 85.45 83.00 84.59 84.59 1,461,130
Feb 2, 2026 82.54 83.35 81.90 83.07 83.07 1,788,931
Jan 30, 2026 83.48 83.70 82.21 82.67 82.67 2,518,439
Jan 29, 2026 82.38 84.30 81.89 83.88 83.88 1,646,754
Jan 28, 2026 81.92 82.63 81.62 81.92 81.92 1,732,406
Jan 27, 2026 81.01 82.52 81.01 82.14 82.14 2,338,625
Jan 26, 2026 79.49 81.28 79.24 81.00 81.00 1,700,602
Jan 23, 2026 81.71 82.20 79.11 80.28 80.28 2,128,921
Jan 22, 2026 79.62 82.19 78.89 81.79 81.79 3,695,674
Jan 21, 2026 77.09 79.54 77.01 79.44 79.44 3,298,663
Jan 20, 2026 75.03 77.99 74.20 77.53 77.53 4,894,345
Jan 16, 2026 77.14 78.00 74.49 76.33 76.33 3,000,587
Jan 15, 2026 79.25 79.75 77.15 77.21 77.21 1,409,021
Jan 14, 2026 79.04 79.57 77.69 78.87 78.87 2,121,498
Jan 13, 2026 82.24 82.57 78.61 79.48 79.48 1,885,179
Jan 12, 2026 80.50 82.21 78.88 81.66 81.66 1,570,607
Jan 9, 2026 82.17 83.23 79.30 80.30 80.30 2,668,760
Jan 8, 2026 83.17 83.79 79.94 81.54 81.54 2,051,548
Jan 7, 2026 82.50 86.15 82.40 83.17 83.17 3,889,646
Jan 6, 2026 78.89 81.54 78.00 81.49 81.49 2,651,738
Jan 5, 2026 79.18 79.42 76.08 78.53 78.53 1,448,687
Jan 2, 2026 79.88 80.21 78.02 79.67 79.67 1,400,448
Dec 31, 2025 78.78 79.84 78.63 79.11 79.11 1,096,900
Dec 30, 2025 79.50 79.99 78.52 78.97 78.97 1,146,166
Dec 29, 2025 79.73 80.04 78.74 79.98 79.98 1,077,894
Dec 26, 2025 80.15 80.42 79.18 79.93 79.93 725,281
Dec 24, 2025 80.33 81.02 80.33 80.65 80.65 480,227
Dec 23, 2025 80.61 81.84 79.63 80.33 80.33 1,229,924
Dec 22, 2025 79.26 82.09 79.09 81.34 81.34 2,257,844
Dec 19, 2025 77.80 79.83 77.63 79.57 79.57 3,557,484
Dec 18, 2025 77.39 78.16 76.69 77.63 77.63 1,765,565
Dec 17, 2025 78.77 79.49 77.07 77.08 77.08 2,146,201
Dec 16, 2025 79.41 79.56 77.16 78.37 78.37 1,959,742
Dec 15, 2025 80.35 81.00 79.31 79.76 79.76 1,977,626
Dec 12, 2025 79.19 80.92 78.50 80.82 80.82 1,468,893
Dec 11, 2025 78.63 79.86 78.05 79.14 79.14 2,052,200
Dec 10, 2025 79.38 79.71 77.79 78.63 78.63 2,659,323
Dec 9, 2025 80.55 81.22 78.32 78.86 78.86 1,866,337
Dec 8, 2025 82.12 82.86 81.18 81.51 81.51 1,553,583
Dec 5, 2025 82.19 82.44 80.64 81.68 81.68 1,714,986
Dec 4, 2025 81.90 83.61 81.44 81.81 81.81 2,317,827
Dec 3, 2025 81.70 83.09 80.98 81.84 81.84 2,531,161
Dec 2, 2025 82.38 82.69 80.00 81.31 81.31 2,454,566
Dec 1, 2025 82.03 82.27 80.11 81.99 81.99 1,865,505
Nov 28, 2025 82.59 82.95 81.67 82.73 82.73 852,943
Nov 26, 2025 81.15 82.91 80.75 82.70 82.70 2,955,547
Nov 25, 2025 78.52 81.20 78.33 80.93 80.93 2,543,172
Nov 24, 2025 76.34 78.79 76.16 78.52 78.52 3,217,036
Nov 21, 2025 73.00 76.31 73.00 76.09 76.09 2,076,032
Nov 20, 2025 74.17 75.40 72.50 73.12 73.12 3,208,760
Nov 19, 2025 74.55 75.00 71.83 74.00 74.00 3,620,815
Nov 18, 2025 72.81 74.52 71.99 74.50 74.50 2,056,681
Nov 17, 2025 70.70 74.42 70.69 73.26 73.26 3,504,705
Nov 14, 2025 69.66 72.54 68.90 71.55 71.55 3,372,265
Nov 13, 2025 72.56 73.05 68.22 69.84 69.84 11,502,846
Nov 12, 2025 71.19 74.50 70.40 72.67 72.67 5,067,958
Nov 11, 2025 69.32 72.79 68.55 72.45 72.45 2,268,649
Nov 10, 2025 70.05 71.49 66.66 69.54 69.54 4,399,684
Nov 7, 2025 73.58 75.00 72.36 73.55 73.55 2,332,419
Nov 6, 2025 74.58 76.78 73.91 74.10 74.10 2,424,206
Nov 5, 2025 72.14 75.08 71.48 74.68 74.68 2,259,305
Nov 4, 2025 72.40 74.21 72.40 72.88 72.88 1,726,391
Nov 3, 2025 74.77 75.25 71.95 73.65 73.65 2,576,035
Oct 31, 2025 74.50 75.49 74.02 74.30 74.30 2,395,612
Oct 30, 2025 71.91 74.70 71.66 74.17 74.17 2,177,727
Oct 29, 2025 72.37 74.05 71.14 71.88 71.88 2,164,198
Oct 28, 2025 72.99 74.04 72.50 73.57 73.57 2,559,568
Oct 27, 2025 72.03 73.27 71.46 72.99 72.99 1,842,613
Oct 24, 2025 72.39 72.44 70.22 70.86 70.86 1,990,370
Oct 23, 2025 71.69 72.44 71.05 71.50 71.50 1,605,852
Oct 22, 2025 71.23 71.98 70.60 71.50 71.50 1,508,356
Oct 21, 2025 72.94 73.20 70.47 71.64 71.64 2,529,928
Oct 20, 2025 73.55 73.69 72.30 73.55 73.55 1,395,624
Oct 17, 2025 72.96 74.02 72.32 73.09 73.09 1,310,772
Oct 16, 2025 73.12 74.42 72.07 73.07 73.07 1,739,636
Oct 15, 2025 71.42 73.92 71.24 72.39 72.39 3,234,234
Oct 14, 2025 70.59 72.15 70.08 71.37 71.37 1,264,896
Oct 13, 2025 70.16 71.50 69.84 70.59 70.59 2,624,101
Oct 10, 2025 70.00 70.49 69.40 69.97 69.97 1,697,166
Oct 9, 2025 70.21 70.89 69.68 70.27 70.27 1,959,024
Oct 8, 2025 70.49 71.87 69.60 69.96 69.96 3,102,776
Oct 7, 2025 69.00 69.77 67.95 68.94 68.94 1,903,691
Oct 6, 2025 69.15 70.14 68.85 69.02 69.02 1,824,037
Oct 3, 2025 68.33 69.25 67.64 69.15 69.15 2,579,755
Oct 2, 2025 66.21 68.41 65.97 68.40 68.40 2,999,333
Oct 1, 2025 65.35 66.25 64.92 65.80 65.80 2,222,143
Sep 30, 2025 63.90 65.55 63.66 65.42 65.42 2,140,270
Sep 29, 2025 63.76 64.70 63.36 64.15 64.15 1,454,533
Sep 26, 2025 64.03 64.49 63.05 64.09 64.09 1,522,295
Sep 25, 2025 63.47 64.07 62.72 62.97 62.97 2,314,520
Sep 24, 2025 62.65 63.99 62.19 63.94 63.94 1,592,919
Sep 23, 2025 61.51 63.13 61.03 62.57 62.57 2,066,238
Sep 22, 2025 63.18 63.18 61.05 61.36 61.36 2,682,881

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Ionis Pharmaceuticals, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at IONS, per a recent SEC DEF 14A filing. We estimate that the median employee at IONIS PHARMACEUTICALS INC is paid $220,397.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation